nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—Pimecrolimus—atopic dermatitis	0.41	1	CrCtD
Tacrolimus—MTOR—Pimecrolimus—atopic dermatitis	0.115	0.468	CbGbCtD
Tacrolimus—FKBP1A—Pimecrolimus—atopic dermatitis	0.0998	0.405	CbGbCtD
Tacrolimus—Everolimus—Pimecrolimus—atopic dermatitis	0.0876	0.333	CrCrCtD
Tacrolimus—Sirolimus—Pimecrolimus—atopic dermatitis	0.0876	0.333	CrCrCtD
Tacrolimus—Temsirolimus—Pimecrolimus—atopic dermatitis	0.0876	0.333	CrCrCtD
Tacrolimus—CYP3A4—Pimecrolimus—atopic dermatitis	0.00283	0.0115	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00234	0.0095	CbGbCtD
Tacrolimus—CYP3A7—Hydrocortisone—atopic dermatitis	0.00234	0.0095	CbGbCtD
Tacrolimus—ALB—Prednisone—atopic dermatitis	0.00218	0.00883	CbGbCtD
Tacrolimus—ABCB1—Loratadine—atopic dermatitis	0.00205	0.00833	CbGbCtD
Tacrolimus—ABCB1—Methylprednisolone—atopic dermatitis	0.00188	0.00762	CbGbCtD
Tacrolimus—CYP3A5—Hydrocortisone—atopic dermatitis	0.00176	0.00712	CbGbCtD
Tacrolimus—CYP3A7—Dexamethasone—atopic dermatitis	0.00146	0.00591	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00146	0.00591	CbGbCtD
Tacrolimus—CYP3A4—Loratadine—atopic dermatitis	0.00123	0.00499	CbGbCtD
Tacrolimus—ABCB1—Betamethasone—atopic dermatitis	0.00122	0.00496	CbGbCtD
Tacrolimus—ABCB1—Prednisolone—atopic dermatitis	0.00121	0.00489	CbGbCtD
Tacrolimus—ABCB1—Hydrocortisone—atopic dermatitis	0.00114	0.00464	CbGbCtD
Tacrolimus—ABCB1—Prednisone—atopic dermatitis	0.00114	0.00462	CbGbCtD
Tacrolimus—CYP3A4—Methylprednisolone—atopic dermatitis	0.00113	0.00457	CbGbCtD
Tacrolimus—CYP3A5—Dexamethasone—atopic dermatitis	0.00109	0.00443	CbGbCtD
Tacrolimus—CYP3A4—Triamcinolone—atopic dermatitis	0.000853	0.00346	CbGbCtD
Tacrolimus—CYP3A4—Betamethasone—atopic dermatitis	0.000732	0.00297	CbGbCtD
Tacrolimus—CYP3A4—Prednisolone—atopic dermatitis	0.000722	0.00293	CbGbCtD
Tacrolimus—ABCB1—Dexamethasone—atopic dermatitis	0.000711	0.00288	CbGbCtD
Tacrolimus—CYP3A4—Hydrocortisone—atopic dermatitis	0.000685	0.00278	CbGbCtD
Tacrolimus—CYP3A4—Prednisone—atopic dermatitis	0.000682	0.00277	CbGbCtD
Tacrolimus—CYP3A4—Dexamethasone—atopic dermatitis	0.000426	0.00173	CbGbCtD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TNF—atopic dermatitis	2.61e-05	0.00155	CbGpPWpGaD
Tacrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MAPK8—atopic dermatitis	2.6e-05	0.00155	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—NFKBIA—atopic dermatitis	2.59e-05	0.00154	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	2.56e-05	0.00152	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IFNG—atopic dermatitis	2.56e-05	0.00152	CbGpPWpGaD
Tacrolimus—MTOR—TSLP Signaling Pathway—IL6—atopic dermatitis	2.54e-05	0.00151	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FCER2—atopic dermatitis	2.52e-05	0.0015	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—atopic dermatitis	2.5e-05	0.00149	CbGpPWpGaD
Tacrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.46e-05	0.00146	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—SLC11A1—atopic dermatitis	2.46e-05	0.00146	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCL17—atopic dermatitis	2.41e-05	0.00143	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—TAC1—atopic dermatitis	2.39e-05	0.00142	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—NPS—atopic dermatitis	2.39e-05	0.00142	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—KIF3A—atopic dermatitis	2.39e-05	0.00142	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—atopic dermatitis	2.38e-05	0.00141	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—NGF—atopic dermatitis	2.36e-05	0.0014	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL10—atopic dermatitis	2.35e-05	0.0014	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CXCR3—atopic dermatitis	2.35e-05	0.00139	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCL22—atopic dermatitis	2.34e-05	0.00139	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.3e-05	0.00137	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKBIA—atopic dermatitis	2.3e-05	0.00137	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL4—atopic dermatitis	2.29e-05	0.00136	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—atopic dermatitis	2.28e-05	0.00136	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	2.25e-05	0.00134	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	2.25e-05	0.00133	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—IFNG—atopic dermatitis	2.24e-05	0.00133	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL5—atopic dermatitis	2.22e-05	0.00132	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKBIA—atopic dermatitis	2.2e-05	0.0013	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FCER1A—atopic dermatitis	2.19e-05	0.0013	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—IL6—atopic dermatitis	2.16e-05	0.00129	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—KIF3A—atopic dermatitis	2.15e-05	0.00128	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CASP1—atopic dermatitis	2.14e-05	0.00127	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—STAT6—atopic dermatitis	2.12e-05	0.00126	CbGpPWpGaD
Tacrolimus—MTOR—ErbB1 downstream signaling—MAPK8—atopic dermatitis	2.09e-05	0.00124	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCL27—atopic dermatitis	2.09e-05	0.00124	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CARD11—atopic dermatitis	2.06e-05	0.00122	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MS4A2—atopic dermatitis	2.04e-05	0.00121	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL5—atopic dermatitis	2.03e-05	0.00121	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—NFKBIA—atopic dermatitis	2.03e-05	0.00121	CbGpPWpGaD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	2.02e-05	0.0012	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—IL1B—atopic dermatitis	2e-05	0.00119	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CARD11—atopic dermatitis	1.98e-05	0.00118	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—atopic dermatitis	1.98e-05	0.00118	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—NFKBIA—atopic dermatitis	1.96e-05	0.00116	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCL11—atopic dermatitis	1.95e-05	0.00116	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CMA1—atopic dermatitis	1.95e-05	0.00116	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—TLR2—atopic dermatitis	1.94e-05	0.00115	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—SLC11A1—atopic dermatitis	1.9e-05	0.00113	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CXCL10—atopic dermatitis	1.9e-05	0.00113	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCL17—atopic dermatitis	1.87e-05	0.00111	CbGpPWpGaD
Tacrolimus—ALB—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	1.85e-05	0.0011	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—STAT6—atopic dermatitis	1.83e-05	0.00109	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.82e-05	0.00108	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD79A—atopic dermatitis	1.82e-05	0.00108	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IFNG—atopic dermatitis	1.82e-05	0.00108	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—DEFB1—atopic dermatitis	1.81e-05	0.00108	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—NGF—atopic dermatitis	1.81e-05	0.00108	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CASP8—atopic dermatitis	1.76e-05	0.00105	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—KIF3A—atopic dermatitis	1.67e-05	0.000991	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CCL5—atopic dermatitis	1.63e-05	0.00097	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	1.63e-05	0.000966	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL1B—atopic dermatitis	1.62e-05	0.000966	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—MAPK8—atopic dermatitis	1.62e-05	0.000966	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL2—atopic dermatitis	1.62e-05	0.000962	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	1.61e-05	0.000958	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CASP1—atopic dermatitis	1.61e-05	0.000954	CbGpPWpGaD
Tacrolimus—MTOR—Disease—GLB1—atopic dermatitis	1.6e-05	0.00095	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCR3—atopic dermatitis	1.59e-05	0.000943	CbGpPWpGaD
Tacrolimus—MTOR—IRS-mediated signalling—IL6—atopic dermatitis	1.58e-05	0.00094	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events—IL6—atopic dermatitis	1.54e-05	0.000914	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events triggered by IGF1R—IL6—atopic dermatitis	1.52e-05	0.000906	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CMA1—atopic dermatitis	1.51e-05	0.000897	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCL11—atopic dermatitis	1.51e-05	0.000897	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—NFKBIA—atopic dermatitis	1.5e-05	0.000889	CbGpPWpGaD
Tacrolimus—MTOR—Insulin Signaling—MAPK8—atopic dermatitis	1.49e-05	0.000887	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL18—atopic dermatitis	1.49e-05	0.000887	CbGpPWpGaD
Tacrolimus—MTOR—Insulin receptor signalling cascade—IL6—atopic dermatitis	1.48e-05	0.000882	CbGpPWpGaD
Tacrolimus—MTOR—IGF1R signaling cascade—IL6—atopic dermatitis	1.48e-05	0.000882	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	1.48e-05	0.000879	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.48e-05	0.000878	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CCR5—atopic dermatitis	1.47e-05	0.000874	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD8A—atopic dermatitis	1.47e-05	0.000873	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—TLR2—atopic dermatitis	1.45e-05	0.000863	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—KIF3A—atopic dermatitis	1.45e-05	0.000862	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—TNF—atopic dermatitis	1.45e-05	0.000861	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CD4—atopic dermatitis	1.45e-05	0.000861	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IFNG—atopic dermatitis	1.45e-05	0.00086	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—STAT6—atopic dermatitis	1.42e-05	0.000843	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FCER2—atopic dermatitis	1.42e-05	0.000842	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NPS—atopic dermatitis	1.41e-05	0.00084	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TAC1—atopic dermatitis	1.41e-05	0.00084	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CXCR3—atopic dermatitis	1.39e-05	0.000824	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	1.38e-05	0.000822	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	1.38e-05	0.000819	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—KIF3A—atopic dermatitis	1.36e-05	0.000808	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	1.34e-05	0.000794	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL22—atopic dermatitis	1.32e-05	0.000782	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	1.32e-05	0.000782	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL5—atopic dermatitis	1.31e-05	0.000781	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD79A—atopic dermatitis	1.31e-05	0.000779	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL1B—atopic dermatitis	1.29e-05	0.000767	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	1.29e-05	0.000764	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—IL6—atopic dermatitis	1.24e-05	0.000738	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CCR5—atopic dermatitis	1.24e-05	0.000737	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—STAT6—atopic dermatitis	1.23e-05	0.000733	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by Insulin receptor—IL6—atopic dermatitis	1.23e-05	0.000733	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	1.23e-05	0.000733	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCR3—atopic dermatitis	1.23e-05	0.000731	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL2—atopic dermatitis	1.23e-05	0.00073	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—MAPK8—atopic dermatitis	1.23e-05	0.000729	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	1.21e-05	0.000722	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CARD11—atopic dermatitis	1.2e-05	0.000713	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TNF—atopic dermatitis	1.18e-05	0.000701	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL27—atopic dermatitis	1.17e-05	0.000697	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—IL6—atopic dermatitis	1.17e-05	0.000695	CbGpPWpGaD
Tacrolimus—Anaphylactic shock—Hydrocortisone—atopic dermatitis	1.17e-05	0.000181	CcSEcCtD
Tacrolimus—Oedema—Hydrocortisone—atopic dermatitis	1.17e-05	0.000181	CcSEcCtD
Tacrolimus—Convulsion—Triamcinolone—atopic dermatitis	1.17e-05	0.000181	CcSEcCtD
Tacrolimus—Tachycardia—Prednisolone—atopic dermatitis	1.17e-05	0.000181	CcSEcCtD
Tacrolimus—Convulsion—Methylprednisolone—atopic dermatitis	1.16e-05	0.000181	CcSEcCtD
Tacrolimus—Hypertension—Triamcinolone—atopic dermatitis	1.16e-05	0.000181	CcSEcCtD
Tacrolimus—Hypertension—Methylprednisolone—atopic dermatitis	1.16e-05	0.00018	CcSEcCtD
Tacrolimus—Infection—Hydrocortisone—atopic dermatitis	1.16e-05	0.00018	CcSEcCtD
Tacrolimus—Hyperhidrosis—Prednisolone—atopic dermatitis	1.15e-05	0.000179	CcSEcCtD
Tacrolimus—Shock—Hydrocortisone—atopic dermatitis	1.15e-05	0.000178	CcSEcCtD
Tacrolimus—Myalgia—Triamcinolone—atopic dermatitis	1.15e-05	0.000178	CcSEcCtD
Tacrolimus—Nervous system disorder—Hydrocortisone—atopic dermatitis	1.14e-05	0.000178	CcSEcCtD
Tacrolimus—Myalgia—Methylprednisolone—atopic dermatitis	1.14e-05	0.000178	CcSEcCtD
Tacrolimus—Arthralgia—Methylprednisolone—atopic dermatitis	1.14e-05	0.000178	CcSEcCtD
Tacrolimus—Eye disorder—Prednisone—atopic dermatitis	1.14e-05	0.000177	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—NFKBIA—atopic dermatitis	1.14e-05	0.000677	CbGpPWpGaD
Tacrolimus—Anxiety—Methylprednisolone—atopic dermatitis	1.14e-05	0.000177	CcSEcCtD
Tacrolimus—Tachycardia—Hydrocortisone—atopic dermatitis	1.14e-05	0.000177	CcSEcCtD
Tacrolimus—MTOR—Cellular responses to stress—CXCL8—atopic dermatitis	1.14e-05	0.000676	CbGpPWpGaD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	1.14e-05	0.000176	CcSEcCtD
Tacrolimus—Flushing—Prednisone—atopic dermatitis	1.13e-05	0.000176	CcSEcCtD
Tacrolimus—Skin disorder—Hydrocortisone—atopic dermatitis	1.13e-05	0.000176	CcSEcCtD
Tacrolimus—Ill-defined disorder—Dexamethasone—atopic dermatitis	1.13e-05	0.000176	CcSEcCtD
Tacrolimus—Ill-defined disorder—Betamethasone—atopic dermatitis	1.13e-05	0.000176	CcSEcCtD
Tacrolimus—Discomfort—Triamcinolone—atopic dermatitis	1.13e-05	0.000176	CcSEcCtD
Tacrolimus—Discomfort—Methylprednisolone—atopic dermatitis	1.13e-05	0.000176	CcSEcCtD
Tacrolimus—Hyperhidrosis—Hydrocortisone—atopic dermatitis	1.13e-05	0.000175	CcSEcCtD
Tacrolimus—Dry mouth—Triamcinolone—atopic dermatitis	1.12e-05	0.000174	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—CXCL10—atopic dermatitis	1.12e-05	0.000666	CbGpPWpGaD
Tacrolimus—Anorexia—Hydrocortisone—atopic dermatitis	1.11e-05	0.000173	CcSEcCtD
Tacrolimus—Angiopathy—Prednisone—atopic dermatitis	1.11e-05	0.000172	CcSEcCtD
Tacrolimus—Confusional state—Methylprednisolone—atopic dermatitis	1.1e-05	0.000172	CcSEcCtD
Tacrolimus—Immune system disorder—Prednisone—atopic dermatitis	1.1e-05	0.000172	CcSEcCtD
Tacrolimus—Malaise—Dexamethasone—atopic dermatitis	1.1e-05	0.000171	CcSEcCtD
Tacrolimus—Malaise—Betamethasone—atopic dermatitis	1.1e-05	0.000171	CcSEcCtD
Tacrolimus—Oedema—Triamcinolone—atopic dermatitis	1.1e-05	0.000171	CcSEcCtD
Tacrolimus—Anaphylactic shock—Triamcinolone—atopic dermatitis	1.1e-05	0.000171	CcSEcCtD
Tacrolimus—Vertigo—Dexamethasone—atopic dermatitis	1.1e-05	0.000171	CcSEcCtD
Tacrolimus—Vertigo—Betamethasone—atopic dermatitis	1.1e-05	0.000171	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—TAC1—atopic dermatitis	1.1e-05	0.000651	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NPS—atopic dermatitis	1.1e-05	0.000651	CbGpPWpGaD
Tacrolimus—Anaphylactic shock—Methylprednisolone—atopic dermatitis	1.1e-05	0.00017	CcSEcCtD
Tacrolimus—ALB—Hemostasis—SELE—atopic dermatitis	1.1e-05	0.000651	CbGpPWpGaD
Tacrolimus—Syncope—Betamethasone—atopic dermatitis	1.09e-05	0.00017	CcSEcCtD
Tacrolimus—Syncope—Dexamethasone—atopic dermatitis	1.09e-05	0.00017	CcSEcCtD
Tacrolimus—Arrhythmia—Prednisone—atopic dermatitis	1.09e-05	0.00017	CcSEcCtD
Tacrolimus—Infection—Triamcinolone—atopic dermatitis	1.09e-05	0.00017	CcSEcCtD
Tacrolimus—Hypotension—Hydrocortisone—atopic dermatitis	1.09e-05	0.000169	CcSEcCtD
Tacrolimus—Infection—Methylprednisolone—atopic dermatitis	1.09e-05	0.000169	CcSEcCtD
Tacrolimus—Shock—Triamcinolone—atopic dermatitis	1.08e-05	0.000168	CcSEcCtD
Tacrolimus—Insomnia—Prednisolone—atopic dermatitis	1.08e-05	0.000168	CcSEcCtD
Tacrolimus—Alopecia—Prednisone—atopic dermatitis	1.08e-05	0.000168	CcSEcCtD
Tacrolimus—Shock—Methylprednisolone—atopic dermatitis	1.08e-05	0.000168	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—CXCR3—atopic dermatitis	1.07e-05	0.000639	CbGpPWpGaD
Tacrolimus—Nervous system disorder—Methylprednisolone—atopic dermatitis	1.07e-05	0.000167	CcSEcCtD
Tacrolimus—Loss of consciousness—Betamethasone—atopic dermatitis	1.07e-05	0.000167	CcSEcCtD
Tacrolimus—Loss of consciousness—Dexamethasone—atopic dermatitis	1.07e-05	0.000167	CcSEcCtD
Tacrolimus—Paraesthesia—Prednisolone—atopic dermatitis	1.07e-05	0.000167	CcSEcCtD
Tacrolimus—Tachycardia—Triamcinolone—atopic dermatitis	1.07e-05	0.000167	CcSEcCtD
Tacrolimus—MTOR—Disease—SLC11A1—atopic dermatitis	1.07e-05	0.000636	CbGpPWpGaD
Tacrolimus—Mental disorder—Prednisone—atopic dermatitis	1.07e-05	0.000166	CcSEcCtD
Tacrolimus—Tachycardia—Methylprednisolone—atopic dermatitis	1.07e-05	0.000166	CcSEcCtD
Tacrolimus—Skin disorder—Methylprednisolone—atopic dermatitis	1.06e-05	0.000165	CcSEcCtD
Tacrolimus—Malnutrition—Prednisone—atopic dermatitis	1.06e-05	0.000165	CcSEcCtD
Tacrolimus—Erythema—Prednisone—atopic dermatitis	1.06e-05	0.000165	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	1.06e-05	0.000165	CcSEcCtD
Tacrolimus—Hyperhidrosis—Triamcinolone—atopic dermatitis	1.06e-05	0.000165	CcSEcCtD
Tacrolimus—Hyperhidrosis—Methylprednisolone—atopic dermatitis	1.06e-05	0.000165	CcSEcCtD
Tacrolimus—Convulsion—Betamethasone—atopic dermatitis	1.06e-05	0.000164	CcSEcCtD
Tacrolimus—Convulsion—Dexamethasone—atopic dermatitis	1.06e-05	0.000164	CcSEcCtD
Tacrolimus—CYP3A7—Metabolism—GLB1—atopic dermatitis	1.06e-05	0.000628	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD8A—atopic dermatitis	1.06e-05	0.000628	CbGpPWpGaD
Tacrolimus—Insomnia—Hydrocortisone—atopic dermatitis	1.05e-05	0.000164	CcSEcCtD
Tacrolimus—MTOR—Signaling by SCF-KIT—IL6—atopic dermatitis	1.05e-05	0.000627	CbGpPWpGaD
Tacrolimus—Hypertension—Betamethasone—atopic dermatitis	1.05e-05	0.000164	CcSEcCtD
Tacrolimus—Hypertension—Dexamethasone—atopic dermatitis	1.05e-05	0.000164	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—CCL17—atopic dermatitis	1.05e-05	0.000626	CbGpPWpGaD
Tacrolimus—Paraesthesia—Hydrocortisone—atopic dermatitis	1.05e-05	0.000163	CcSEcCtD
Tacrolimus—Myalgia—Dexamethasone—atopic dermatitis	1.04e-05	0.000162	CcSEcCtD
Tacrolimus—Myalgia—Betamethasone—atopic dermatitis	1.04e-05	0.000162	CcSEcCtD
Tacrolimus—Anxiety—Dexamethasone—atopic dermatitis	1.04e-05	0.000161	CcSEcCtD
Tacrolimus—Anxiety—Betamethasone—atopic dermatitis	1.04e-05	0.000161	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—CASP8—atopic dermatitis	1.03e-05	0.000611	CbGpPWpGaD
Tacrolimus—Discomfort—Dexamethasone—atopic dermatitis	1.03e-05	0.00016	CcSEcCtD
Tacrolimus—Discomfort—Betamethasone—atopic dermatitis	1.03e-05	0.00016	CcSEcCtD
Tacrolimus—Dyspepsia—Hydrocortisone—atopic dermatitis	1.03e-05	0.00016	CcSEcCtD
Tacrolimus—Hypotension—Methylprednisolone—atopic dermatitis	1.02e-05	0.000159	CcSEcCtD
Tacrolimus—Pain—Prednisolone—atopic dermatitis	1.02e-05	0.000159	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—IL5—atopic dermatitis	1.02e-05	0.000606	CbGpPWpGaD
Tacrolimus—Decreased appetite—Hydrocortisone—atopic dermatitis	1.01e-05	0.000158	CcSEcCtD
Tacrolimus—CYP3A7—Metabolism—ADSL—atopic dermatitis	1.01e-05	0.000602	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—IL6—atopic dermatitis	1.01e-05	0.0006	CbGpPWpGaD
Tacrolimus—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	1.01e-05	0.000157	CcSEcCtD
Tacrolimus—Fatigue—Hydrocortisone—atopic dermatitis	1.01e-05	0.000156	CcSEcCtD
Tacrolimus—Vision blurred—Prednisone—atopic dermatitis	1e-05	0.000156	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	1e-05	0.000156	CcSEcCtD
Tacrolimus—MTOR—Cellular responses to stress—MAPK8—atopic dermatitis	1e-05	0.000595	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	9.98e-06	0.000155	CcSEcCtD
Tacrolimus—Pain—Hydrocortisone—atopic dermatitis	9.97e-06	0.000155	CcSEcCtD
Tacrolimus—Anaphylactic shock—Dexamethasone—atopic dermatitis	9.96e-06	0.000155	CcSEcCtD
Tacrolimus—Anaphylactic shock—Betamethasone—atopic dermatitis	9.96e-06	0.000155	CcSEcCtD
Tacrolimus—Oedema—Betamethasone—atopic dermatitis	9.96e-06	0.000155	CcSEcCtD
Tacrolimus—Oedema—Dexamethasone—atopic dermatitis	9.96e-06	0.000155	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB4—IL6—atopic dermatitis	9.93e-06	0.00059	CbGpPWpGaD
Tacrolimus—Insomnia—Triamcinolone—atopic dermatitis	9.93e-06	0.000154	CcSEcCtD
Tacrolimus—Insomnia—Methylprednisolone—atopic dermatitis	9.91e-06	0.000154	CcSEcCtD
Tacrolimus—Infection—Betamethasone—atopic dermatitis	9.9e-06	0.000154	CcSEcCtD
Tacrolimus—Infection—Dexamethasone—atopic dermatitis	9.9e-06	0.000154	CcSEcCtD
Tacrolimus—Ill-defined disorder—Prednisone—atopic dermatitis	9.87e-06	0.000153	CcSEcCtD
Tacrolimus—Paraesthesia—Triamcinolone—atopic dermatitis	9.86e-06	0.000153	CcSEcCtD
Tacrolimus—Feeling abnormal—Prednisolone—atopic dermatitis	9.84e-06	0.000153	CcSEcCtD
Tacrolimus—Paraesthesia—Methylprednisolone—atopic dermatitis	9.84e-06	0.000153	CcSEcCtD
Tacrolimus—Anaemia—Prednisone—atopic dermatitis	9.83e-06	0.000153	CcSEcCtD
Tacrolimus—Shock—Dexamethasone—atopic dermatitis	9.8e-06	0.000152	CcSEcCtD
Tacrolimus—Shock—Betamethasone—atopic dermatitis	9.8e-06	0.000152	CcSEcCtD
Tacrolimus—Dyspnoea—Triamcinolone—atopic dermatitis	9.79e-06	0.000152	CcSEcCtD
Tacrolimus—Nervous system disorder—Betamethasone—atopic dermatitis	9.77e-06	0.000152	CcSEcCtD
Tacrolimus—Nervous system disorder—Dexamethasone—atopic dermatitis	9.77e-06	0.000152	CcSEcCtD
Tacrolimus—Agitation—Prednisone—atopic dermatitis	9.77e-06	0.000152	CcSEcCtD
Tacrolimus—Thrombocytopenia—Dexamethasone—atopic dermatitis	9.76e-06	0.000152	CcSEcCtD
Tacrolimus—Thrombocytopenia—Betamethasone—atopic dermatitis	9.76e-06	0.000152	CcSEcCtD
Tacrolimus—Tachycardia—Dexamethasone—atopic dermatitis	9.73e-06	0.000151	CcSEcCtD
Tacrolimus—Tachycardia—Betamethasone—atopic dermatitis	9.73e-06	0.000151	CcSEcCtD
Tacrolimus—Dyspepsia—Triamcinolone—atopic dermatitis	9.67e-06	0.00015	CcSEcCtD
Tacrolimus—Dyspepsia—Methylprednisolone—atopic dermatitis	9.65e-06	0.00015	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—CCL5—atopic dermatitis	9.64e-06	0.000573	CbGpPWpGaD
Tacrolimus—Hyperhidrosis—Betamethasone—atopic dermatitis	9.63e-06	0.00015	CcSEcCtD
Tacrolimus—Hyperhidrosis—Dexamethasone—atopic dermatitis	9.63e-06	0.00015	CcSEcCtD
Tacrolimus—FKBP1A—Disease—CCR5—atopic dermatitis	9.62e-06	0.000572	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Hydrocortisone—atopic dermatitis	9.61e-06	0.000149	CcSEcCtD
Tacrolimus—Malaise—Prednisone—atopic dermatitis	9.59e-06	0.000149	CcSEcCtD
Tacrolimus—Vertigo—Prednisone—atopic dermatitis	9.55e-06	0.000149	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	9.54e-06	0.000148	CcSEcCtD
Tacrolimus—Syncope—Prednisone—atopic dermatitis	9.54e-06	0.000148	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—IL6—atopic dermatitis	9.51e-06	0.000565	CbGpPWpGaD
Tacrolimus—Anorexia—Betamethasone—atopic dermatitis	9.5e-06	0.000148	CcSEcCtD
Tacrolimus—Anorexia—Dexamethasone—atopic dermatitis	9.5e-06	0.000148	CcSEcCtD
Tacrolimus—Urticaria—Prednisolone—atopic dermatitis	9.49e-06	0.000147	CcSEcCtD
Tacrolimus—MTOR—Downstream signal transduction—IL6—atopic dermatitis	9.49e-06	0.000564	CbGpPWpGaD
Tacrolimus—Fatigue—Triamcinolone—atopic dermatitis	9.47e-06	0.000147	CcSEcCtD
Tacrolimus—Fatigue—Methylprednisolone—atopic dermatitis	9.45e-06	0.000147	CcSEcCtD
Tacrolimus—MTOR—Signaling by FGFR—IL6—atopic dermatitis	9.44e-06	0.000561	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	9.41e-06	0.000559	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—IL6—atopic dermatitis	9.39e-06	0.000558	CbGpPWpGaD
Tacrolimus—Pain—Triamcinolone—atopic dermatitis	9.39e-06	0.000146	CcSEcCtD
Tacrolimus—MTOR—Signaling by NGF—MAPK8—atopic dermatitis	9.38e-06	0.000558	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KIF3A—atopic dermatitis	9.38e-06	0.000558	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	9.37e-06	0.000557	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CASP1—atopic dermatitis	9.35e-06	0.000556	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—IL6—atopic dermatitis	9.35e-06	0.000556	CbGpPWpGaD
Tacrolimus—Loss of consciousness—Prednisone—atopic dermatitis	9.35e-06	0.000145	CcSEcCtD
Tacrolimus—Hypotension—Dexamethasone—atopic dermatitis	9.31e-06	0.000145	CcSEcCtD
Tacrolimus—Hypotension—Betamethasone—atopic dermatitis	9.31e-06	0.000145	CcSEcCtD
Tacrolimus—Urticaria—Hydrocortisone—atopic dermatitis	9.27e-06	0.000144	CcSEcCtD
Tacrolimus—Abdominal pain—Hydrocortisone—atopic dermatitis	9.22e-06	0.000143	CcSEcCtD
Tacrolimus—Body temperature increased—Hydrocortisone—atopic dermatitis	9.22e-06	0.000143	CcSEcCtD
Tacrolimus—Convulsion—Prednisone—atopic dermatitis	9.21e-06	0.000143	CcSEcCtD
Tacrolimus—Hypertension—Prednisone—atopic dermatitis	9.18e-06	0.000143	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	9.08e-06	0.000141	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	9.08e-06	0.000141	CcSEcCtD
Tacrolimus—Myalgia—Prednisone—atopic dermatitis	9.05e-06	0.000141	CcSEcCtD
Tacrolimus—Arthralgia—Prednisone—atopic dermatitis	9.05e-06	0.000141	CcSEcCtD
Tacrolimus—Feeling abnormal—Triamcinolone—atopic dermatitis	9.05e-06	0.000141	CcSEcCtD
Tacrolimus—Feeling abnormal—Methylprednisolone—atopic dermatitis	9.03e-06	0.00014	CcSEcCtD
Tacrolimus—Anxiety—Prednisone—atopic dermatitis	9.02e-06	0.00014	CcSEcCtD
Tacrolimus—Insomnia—Betamethasone—atopic dermatitis	9.01e-06	0.00014	CcSEcCtD
Tacrolimus—Insomnia—Dexamethasone—atopic dermatitis	9.01e-06	0.00014	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	8.99e-06	0.00014	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	8.96e-06	0.000139	CcSEcCtD
Tacrolimus—Paraesthesia—Dexamethasone—atopic dermatitis	8.95e-06	0.000139	CcSEcCtD
Tacrolimus—Paraesthesia—Betamethasone—atopic dermatitis	8.95e-06	0.000139	CcSEcCtD
Tacrolimus—ABCB1—Allograft Rejection—TNF—atopic dermatitis	8.95e-06	0.000532	CbGpPWpGaD
Tacrolimus—Discomfort—Prednisone—atopic dermatitis	8.94e-06	0.000139	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—NGF—atopic dermatitis	8.93e-06	0.000531	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	8.89e-06	0.000529	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CXCL8—atopic dermatitis	8.89e-06	0.000529	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL5—atopic dermatitis	8.86e-06	0.000527	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Prednisolone—atopic dermatitis	8.8e-06	0.000137	CcSEcCtD
Tacrolimus—MTOR—DAP12 interactions—IL6—atopic dermatitis	8.79e-06	0.000523	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	8.79e-06	0.000523	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—IL6—atopic dermatitis	8.79e-06	0.000523	CbGpPWpGaD
Tacrolimus—Dyspepsia—Dexamethasone—atopic dermatitis	8.77e-06	0.000136	CcSEcCtD
Tacrolimus—Dyspepsia—Betamethasone—atopic dermatitis	8.77e-06	0.000136	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—IFNG—atopic dermatitis	8.74e-06	0.000519	CbGpPWpGaD
Tacrolimus—Urticaria—Triamcinolone—atopic dermatitis	8.72e-06	0.000136	CcSEcCtD
Tacrolimus—MTOR—Signaling by EGFR—IL6—atopic dermatitis	8.72e-06	0.000518	CbGpPWpGaD
Tacrolimus—Urticaria—Methylprednisolone—atopic dermatitis	8.71e-06	0.000135	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—CCR5—atopic dermatitis	8.69e-06	0.000516	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL10—atopic dermatitis	8.69e-06	0.000516	CbGpPWpGaD
Tacrolimus—Body temperature increased—Triamcinolone—atopic dermatitis	8.68e-06	0.000135	CcSEcCtD
Tacrolimus—Anaphylactic shock—Prednisone—atopic dermatitis	8.68e-06	0.000135	CcSEcCtD
Tacrolimus—Oedema—Prednisone—atopic dermatitis	8.68e-06	0.000135	CcSEcCtD
Tacrolimus—Abdominal pain—Methylprednisolone—atopic dermatitis	8.66e-06	0.000135	CcSEcCtD
Tacrolimus—Decreased appetite—Betamethasone—atopic dermatitis	8.66e-06	0.000135	CcSEcCtD
Tacrolimus—Decreased appetite—Dexamethasone—atopic dermatitis	8.66e-06	0.000135	CcSEcCtD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—IL6—atopic dermatitis	8.64e-06	0.000513	CbGpPWpGaD
Tacrolimus—Infection—Prednisone—atopic dermatitis	8.62e-06	0.000134	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	8.6e-06	0.000134	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Betamethasone—atopic dermatitis	8.6e-06	0.000134	CcSEcCtD
Tacrolimus—MTOR—Signaling by PDGF—IL6—atopic dermatitis	8.6e-06	0.000511	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.59e-06	0.000134	CcSEcCtD
Tacrolimus—Fatigue—Dexamethasone—atopic dermatitis	8.59e-06	0.000134	CcSEcCtD
Tacrolimus—Fatigue—Betamethasone—atopic dermatitis	8.59e-06	0.000134	CcSEcCtD
Tacrolimus—Shock—Prednisone—atopic dermatitis	8.54e-06	0.000133	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—NFKBIA—atopic dermatitis	8.53e-06	0.000507	CbGpPWpGaD
Tacrolimus—Pain—Betamethasone—atopic dermatitis	8.52e-06	0.000132	CcSEcCtD
Tacrolimus—Pain—Dexamethasone—atopic dermatitis	8.52e-06	0.000132	CcSEcCtD
Tacrolimus—Nervous system disorder—Prednisone—atopic dermatitis	8.51e-06	0.000132	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—IL2—atopic dermatitis	8.5e-06	0.000505	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL11—atopic dermatitis	8.48e-06	0.000504	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CMA1—atopic dermatitis	8.48e-06	0.000504	CbGpPWpGaD
Tacrolimus—Tachycardia—Prednisone—atopic dermatitis	8.47e-06	0.000132	CcSEcCtD
Tacrolimus—MTOR—Immune System—TLR2—atopic dermatitis	8.45e-06	0.000503	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD4—atopic dermatitis	8.44e-06	0.000502	CbGpPWpGaD
Tacrolimus—Skin disorder—Prednisone—atopic dermatitis	8.43e-06	0.000131	CcSEcCtD
Tacrolimus—Hyperhidrosis—Prednisone—atopic dermatitis	8.39e-06	0.00013	CcSEcCtD
Tacrolimus—Asthenia—Hydrocortisone—atopic dermatitis	8.37e-06	0.00013	CcSEcCtD
Tacrolimus—ALB—Hemostasis—IL5—atopic dermatitis	8.3e-06	0.000494	CbGpPWpGaD
Tacrolimus—Anorexia—Prednisone—atopic dermatitis	8.27e-06	0.000129	CcSEcCtD
Tacrolimus—Pruritus—Hydrocortisone—atopic dermatitis	8.25e-06	0.000128	CcSEcCtD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	8.24e-06	0.00049	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Dexamethasone—atopic dermatitis	8.21e-06	0.000128	CcSEcCtD
Tacrolimus—Feeling abnormal—Betamethasone—atopic dermatitis	8.21e-06	0.000128	CcSEcCtD
Tacrolimus—MTOR—Adaptive Immune System—NFKBIA—atopic dermatitis	8.19e-06	0.000487	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Betamethasone—atopic dermatitis	8.15e-06	0.000127	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Dexamethasone—atopic dermatitis	8.15e-06	0.000127	CcSEcCtD
Tacrolimus—Hypersensitivity—Triamcinolone—atopic dermatitis	8.09e-06	0.000126	CcSEcCtD
Tacrolimus—Hypersensitivity—Methylprednisolone—atopic dermatitis	8.07e-06	0.000126	CcSEcCtD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	8.02e-06	0.000477	CbGpPWpGaD
Tacrolimus—Diarrhoea—Hydrocortisone—atopic dermatitis	7.98e-06	0.000124	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—STAT6—atopic dermatitis	7.98e-06	0.000474	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD79A—atopic dermatitis	7.95e-06	0.000472	CbGpPWpGaD
Tacrolimus—Urticaria—Betamethasone—atopic dermatitis	7.92e-06	0.000123	CcSEcCtD
Tacrolimus—Urticaria—Dexamethasone—atopic dermatitis	7.92e-06	0.000123	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Prednisone—atopic dermatitis	7.91e-06	0.000123	CcSEcCtD
Tacrolimus—Dizziness—Prednisolone—atopic dermatitis	7.9e-06	0.000123	CcSEcCtD
Tacrolimus—Asthenia—Triamcinolone—atopic dermatitis	7.88e-06	0.000122	CcSEcCtD
Tacrolimus—Abdominal pain—Betamethasone—atopic dermatitis	7.88e-06	0.000122	CcSEcCtD
Tacrolimus—Body temperature increased—Dexamethasone—atopic dermatitis	7.88e-06	0.000122	CcSEcCtD
Tacrolimus—Body temperature increased—Betamethasone—atopic dermatitis	7.88e-06	0.000122	CcSEcCtD
Tacrolimus—Abdominal pain—Dexamethasone—atopic dermatitis	7.88e-06	0.000122	CcSEcCtD
Tacrolimus—Asthenia—Methylprednisolone—atopic dermatitis	7.86e-06	0.000122	CcSEcCtD
Tacrolimus—Insomnia—Prednisone—atopic dermatitis	7.85e-06	0.000122	CcSEcCtD
Tacrolimus—PPP3CA—Innate Immune System—IL6—atopic dermatitis	7.84e-06	0.000466	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1B—atopic dermatitis	7.79e-06	0.000463	CbGpPWpGaD
Tacrolimus—Paraesthesia—Prednisone—atopic dermatitis	7.79e-06	0.000121	CcSEcCtD
Tacrolimus—PPP3CA—Disease—CD4—atopic dermatitis	7.79e-06	0.000463	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	7.79e-06	0.000463	CbGpPWpGaD
Tacrolimus—Pruritus—Triamcinolone—atopic dermatitis	7.77e-06	0.000121	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—IL2—atopic dermatitis	7.76e-06	0.000462	CbGpPWpGaD
Tacrolimus—Pruritus—Methylprednisolone—atopic dermatitis	7.75e-06	0.000121	CcSEcCtD
Tacrolimus—Dizziness—Hydrocortisone—atopic dermatitis	7.71e-06	0.00012	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—CASP8—atopic dermatitis	7.69e-06	0.000457	CbGpPWpGaD
Tacrolimus—Dyspepsia—Prednisone—atopic dermatitis	7.64e-06	0.000119	CcSEcCtD
Tacrolimus—CYP3A5—Metabolism—GLB1—atopic dermatitis	7.64e-06	0.000454	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	7.56e-06	0.000449	CbGpPWpGaD
Tacrolimus—Decreased appetite—Prednisone—atopic dermatitis	7.54e-06	0.000117	CcSEcCtD
Tacrolimus—Rash—Prednisolone—atopic dermatitis	7.53e-06	0.000117	CcSEcCtD
Tacrolimus—Dermatitis—Prednisolone—atopic dermatitis	7.52e-06	0.000117	CcSEcCtD
Tacrolimus—Diarrhoea—Methylprednisolone—atopic dermatitis	7.5e-06	0.000117	CcSEcCtD
Tacrolimus—Fatigue—Prednisone—atopic dermatitis	7.48e-06	0.000116	CcSEcCtD
Tacrolimus—Headache—Prednisolone—atopic dermatitis	7.48e-06	0.000116	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—CCL5—atopic dermatitis	7.48e-06	0.000444	CbGpPWpGaD
Tacrolimus—Constipation—Prednisone—atopic dermatitis	7.42e-06	0.000115	CcSEcCtD
Tacrolimus—Vomiting—Hydrocortisone—atopic dermatitis	7.42e-06	0.000115	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—NFKBIA—atopic dermatitis	7.37e-06	0.000438	CbGpPWpGaD
Tacrolimus—Rash—Hydrocortisone—atopic dermatitis	7.35e-06	0.000114	CcSEcCtD
Tacrolimus—Dermatitis—Hydrocortisone—atopic dermatitis	7.35e-06	0.000114	CcSEcCtD
Tacrolimus—CYP3A5—Metabolism—ADSL—atopic dermatitis	7.32e-06	0.000435	CbGpPWpGaD
Tacrolimus—Headache—Hydrocortisone—atopic dermatitis	7.31e-06	0.000114	CcSEcCtD
Tacrolimus—Dizziness—Triamcinolone—atopic dermatitis	7.26e-06	0.000113	CcSEcCtD
Tacrolimus—Dizziness—Methylprednisolone—atopic dermatitis	7.25e-06	0.000113	CcSEcCtD
Tacrolimus—Feeling abnormal—Prednisone—atopic dermatitis	7.15e-06	0.000111	CcSEcCtD
Tacrolimus—Asthenia—Dexamethasone—atopic dermatitis	7.15e-06	0.000111	CcSEcCtD
Tacrolimus—Asthenia—Betamethasone—atopic dermatitis	7.15e-06	0.000111	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—MAPK8—atopic dermatitis	7.15e-06	0.000425	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Prednisone—atopic dermatitis	7.1e-06	0.00011	CcSEcCtD
Tacrolimus—Nausea—Prednisolone—atopic dermatitis	7.09e-06	0.00011	CcSEcCtD
Tacrolimus—Pruritus—Betamethasone—atopic dermatitis	7.05e-06	0.00011	CcSEcCtD
Tacrolimus—Pruritus—Dexamethasone—atopic dermatitis	7.05e-06	0.00011	CcSEcCtD
Tacrolimus—Vomiting—Triamcinolone—atopic dermatitis	6.98e-06	0.000109	CcSEcCtD
Tacrolimus—Vomiting—Methylprednisolone—atopic dermatitis	6.97e-06	0.000108	CcSEcCtD
Tacrolimus—Nausea—Hydrocortisone—atopic dermatitis	6.93e-06	0.000108	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—NGF—atopic dermatitis	6.93e-06	0.000412	CbGpPWpGaD
Tacrolimus—Rash—Triamcinolone—atopic dermatitis	6.92e-06	0.000108	CcSEcCtD
Tacrolimus—Dermatitis—Triamcinolone—atopic dermatitis	6.92e-06	0.000108	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—CCR3—atopic dermatitis	6.91e-06	0.000411	CbGpPWpGaD
Tacrolimus—Rash—Methylprednisolone—atopic dermatitis	6.91e-06	0.000107	CcSEcCtD
Tacrolimus—Dermatitis—Methylprednisolone—atopic dermatitis	6.9e-06	0.000107	CcSEcCtD
Tacrolimus—Urticaria—Prednisone—atopic dermatitis	6.89e-06	0.000107	CcSEcCtD
Tacrolimus—Headache—Triamcinolone—atopic dermatitis	6.88e-06	0.000107	CcSEcCtD
Tacrolimus—Headache—Methylprednisolone—atopic dermatitis	6.86e-06	0.000107	CcSEcCtD
Tacrolimus—Body temperature increased—Prednisone—atopic dermatitis	6.86e-06	0.000107	CcSEcCtD
Tacrolimus—Abdominal pain—Prednisone—atopic dermatitis	6.86e-06	0.000107	CcSEcCtD
Tacrolimus—Diarrhoea—Betamethasone—atopic dermatitis	6.82e-06	0.000106	CcSEcCtD
Tacrolimus—Diarrhoea—Dexamethasone—atopic dermatitis	6.82e-06	0.000106	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—CCR5—atopic dermatitis	6.74e-06	0.0004	CbGpPWpGaD
Tacrolimus—Dizziness—Dexamethasone—atopic dermatitis	6.59e-06	0.000102	CcSEcCtD
Tacrolimus—Dizziness—Betamethasone—atopic dermatitis	6.59e-06	0.000102	CcSEcCtD
Tacrolimus—ALB—Metabolism—GLB1—atopic dermatitis	6.58e-06	0.000391	CbGpPWpGaD
Tacrolimus—Nausea—Triamcinolone—atopic dermatitis	6.52e-06	0.000101	CcSEcCtD
Tacrolimus—Nausea—Methylprednisolone—atopic dermatitis	6.51e-06	0.000101	CcSEcCtD
Tacrolimus—MTOR—Immune System—IL18—atopic dermatitis	6.5e-06	0.000387	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD8A—atopic dermatitis	6.41e-06	0.000381	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Prednisone—atopic dermatitis	6.39e-06	9.94e-05	CcSEcCtD
Tacrolimus—MTOR—Cellular responses to stress—IL6—atopic dermatitis	6.39e-06	0.00038	CbGpPWpGaD
Tacrolimus—Vomiting—Betamethasone—atopic dermatitis	6.34e-06	9.85e-05	CcSEcCtD
Tacrolimus—Vomiting—Dexamethasone—atopic dermatitis	6.34e-06	9.85e-05	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—CD4—atopic dermatitis	6.32e-06	0.000376	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ADSL—atopic dermatitis	6.31e-06	0.000375	CbGpPWpGaD
Tacrolimus—Rash—Dexamethasone—atopic dermatitis	6.28e-06	9.77e-05	CcSEcCtD
Tacrolimus—Rash—Betamethasone—atopic dermatitis	6.28e-06	9.77e-05	CcSEcCtD
Tacrolimus—Dermatitis—Dexamethasone—atopic dermatitis	6.28e-06	9.76e-05	CcSEcCtD
Tacrolimus—Dermatitis—Betamethasone—atopic dermatitis	6.28e-06	9.76e-05	CcSEcCtD
Tacrolimus—Headache—Dexamethasone—atopic dermatitis	6.24e-06	9.7e-05	CcSEcCtD
Tacrolimus—Headache—Betamethasone—atopic dermatitis	6.24e-06	9.7e-05	CcSEcCtD
Tacrolimus—Asthenia—Prednisone—atopic dermatitis	6.23e-06	9.68e-05	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—TAC1—atopic dermatitis	6.16e-06	0.000366	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NPS—atopic dermatitis	6.16e-06	0.000366	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	6.16e-06	0.000366	CbGpPWpGaD
Tacrolimus—Pruritus—Prednisone—atopic dermatitis	6.14e-06	9.54e-05	CcSEcCtD
Tacrolimus—MTOR—Adaptive Immune System—CD4—atopic dermatitis	6.07e-06	0.000361	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCR3—atopic dermatitis	6.04e-06	0.000359	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CD4—atopic dermatitis	6.04e-06	0.000359	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—atopic dermatitis	5.99e-06	0.000356	CbGpPWpGaD
Tacrolimus—Diarrhoea—Prednisone—atopic dermatitis	5.94e-06	9.23e-05	CcSEcCtD
Tacrolimus—Nausea—Betamethasone—atopic dermatitis	5.92e-06	9.2e-05	CcSEcCtD
Tacrolimus—Nausea—Dexamethasone—atopic dermatitis	5.92e-06	9.2e-05	CcSEcCtD
Tacrolimus—ABCB1—Metabolism—GLB1—atopic dermatitis	5.76e-06	0.000343	CbGpPWpGaD
Tacrolimus—Dizziness—Prednisone—atopic dermatitis	5.74e-06	8.92e-05	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—IL5—atopic dermatitis	5.73e-06	0.000341	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NFKBIA—atopic dermatitis	5.71e-06	0.000339	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	5.58e-06	0.000332	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ADSL—atopic dermatitis	5.52e-06	0.000328	CbGpPWpGaD
Tacrolimus—Vomiting—Prednisone—atopic dermatitis	5.52e-06	8.58e-05	CcSEcCtD
Tacrolimus—Rash—Prednisone—atopic dermatitis	5.47e-06	8.51e-05	CcSEcCtD
Tacrolimus—Dermatitis—Prednisone—atopic dermatitis	5.47e-06	8.5e-05	CcSEcCtD
Tacrolimus—Headache—Prednisone—atopic dermatitis	5.44e-06	8.45e-05	CcSEcCtD
Tacrolimus—MTOR—Disease—CCR5—atopic dermatitis	5.41e-06	0.000322	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—MAPK8—atopic dermatitis	5.35e-06	0.000318	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CXCL8—atopic dermatitis	5.25e-06	0.000312	CbGpPWpGaD
Tacrolimus—Nausea—Prednisone—atopic dermatitis	5.15e-06	8.01e-05	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—IL2—atopic dermatitis	5.02e-06	0.000298	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—atopic dermatitis	4.99e-06	0.000297	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—NFKBIA—atopic dermatitis	4.97e-06	0.000295	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL10—atopic dermatitis	4.89e-06	0.00029	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.79e-06	0.000285	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MAPK8—atopic dermatitis	4.62e-06	0.000275	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—atopic dermatitis	4.56e-06	0.000271	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.56e-06	0.000271	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CASP8—atopic dermatitis	4.48e-06	0.000266	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	4.41e-06	0.000262	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—atopic dermatitis	4.21e-06	0.00025	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL5—atopic dermatitis	4.21e-06	0.00025	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL8—atopic dermatitis	4.07e-06	0.000242	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.99e-06	0.000237	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NGF—atopic dermatitis	3.89e-06	0.000232	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2—atopic dermatitis	3.89e-06	0.000231	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNG—atopic dermatitis	3.81e-06	0.000226	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCR5—atopic dermatitis	3.79e-06	0.000225	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD4—atopic dermatitis	3.68e-06	0.000219	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAPK8—atopic dermatitis	3.58e-06	0.000213	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.55e-06	0.000211	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PPARA—atopic dermatitis	3.43e-06	0.000204	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—atopic dermatitis	3.42e-06	0.000203	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.4e-06	0.000202	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—atopic dermatitis	3.4e-06	0.000202	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD4—atopic dermatitis	3.4e-06	0.000202	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2—atopic dermatitis	3.39e-06	0.000201	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—atopic dermatitis	3.27e-06	0.000194	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NFKBIA—atopic dermatitis	3.21e-06	0.000191	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2—atopic dermatitis	3.17e-06	0.000189	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MAPK8—atopic dermatitis	3.12e-06	0.000185	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—atopic dermatitis	2.95e-06	0.000175	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARA—atopic dermatitis	2.48e-06	0.000147	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL8—atopic dermatitis	2.29e-06	0.000136	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—atopic dermatitis	2.29e-06	0.000136	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2—atopic dermatitis	2.19e-06	0.00013	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARA—atopic dermatitis	2.13e-06	0.000127	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAPK8—atopic dermatitis	2.02e-06	0.00012	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—atopic dermatitis	1.99e-06	0.000118	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARA—atopic dermatitis	1.87e-06	0.000111	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—atopic dermatitis	1.84e-06	0.000109	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—atopic dermatitis	1.29e-06	7.65e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.15e-06	6.85e-05	CbGpPWpGaD
